These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7148457)

  • 1. Capillarosclerosis of the urinary tract associated with the use of paracetamol and cyclophosphamide.
    Karttunen T; Autio-Harmainen H; Sutinen S
    Acta Pathol Microbiol Immunol Scand A; 1982 Sep; 90(5):391-2. PubMed ID: 7148457
    [No Abstract]   [Full Text] [Related]  

  • 2. Capillarosclerosis of the renal pelvis: autopsy study for estimating the incidence of phenacetin and paracetamol abuse.
    Schubert GE; Bethke BA
    Eur Urol; 1986; 12(5):327-30. PubMed ID: 3780797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-epithelial basement membrane thickening in the urinary tract associated with phenacetin abuse.
    Palvio DH; Falk E; Andersen JC
    Virchows Arch A Pathol Anat Histopathol; 1985; 408(2-3):173-82. PubMed ID: 3936258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Capillarosclerosis of the efferent urinary tract as an indication of analgesic abuse. Incidence in unselected autopsies in a large West German town].
    Bethke BA; Schubert GE
    Dtsch Med Wochenschr; 1985 Mar; 110(9):343-6. PubMed ID: 3971888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Capillarosclerosis of the lower urinary tract and chronic alcohol consumption].
    Zschoch H
    Zentralbl Pathol; 1992 Nov; 138(5):373-4. PubMed ID: 1477087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic abuse and microvascular changes.
    Abrahams C; Furman KI; Salant D
    Am Heart J; 1978 Feb; 95(2):268-9. PubMed ID: 622962
    [No Abstract]   [Full Text] [Related]  

  • 7. Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.
    Brock N; Stekar J; Pohl J; Niemeyer U; Scheffler G
    Arzneimittelforschung; 1979; 29(4):659-61. PubMed ID: 114192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Capillary sclerosis of the urinary tract caused by abuse of an analgesic agent (phenacetin)].
    Gloor F
    Pathologe; 1982 May; 3(3):132-6. PubMed ID: 7111216
    [No Abstract]   [Full Text] [Related]  

  • 9. Uroprotection in patients receiving cyclophosphamide and ifosfamide.
    Munshi NC; Loehrer PJ; Williams SD
    Cancer Treat Res; 1991; 58():119-26. PubMed ID: 1683781
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic role and toxicity of cyclophosphamide].
    Morrone G
    Pediatria (Napoli); 1975 Dec; 83(4):793-808. PubMed ID: 778777
    [No Abstract]   [Full Text] [Related]  

  • 11. Urological implications of cyclophosphamide and ifosfamide.
    Lawson M; Vasilaras A; De Vries A; Mactaggart P; Nicol D
    Scand J Urol Nephrol; 2008; 42(4):309-17. PubMed ID: 18781541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of mesna for the inhibition of urotoxic side effects of cyclophosphamide, ifosfamide, and other oxazaphosphorine cytostatics.
    Brock N
    Recent Results Cancer Res; 1980; 74():270-8. PubMed ID: 6777836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Postoperative complications and histological findings in vterine cervix carcinoma after additional cytostatic therapy].
    Schüssling G; Möbius G; Püschel W
    Geburtshilfe Frauenheilkd; 1968 Jul; 28(7):617-30. PubMed ID: 5681959
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic diseases.
    Kovarsky J
    Semin Arthritis Rheum; 1983 May; 12(4):359-72. PubMed ID: 6348951
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of combined oral contraceptives in the pathogenesis of urodynamic disorders of the upper urinary tracts].
    Datuashvili TD; Khomasuridze AG
    Akush Ginekol (Mosk); 1979 Feb; (2):13-5. PubMed ID: 426211
    [No Abstract]   [Full Text] [Related]  

  • 16. [Paracetamol--kidney and urinary tract. A cause of analgetic nephropathy or cancer?].
    Berg KJ
    Tidsskr Nor Laegeforen; 1994 Apr; 114(10):1169-74. PubMed ID: 8209312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological study of analgesic intake and its relationship to urinary tract disorders in Switzerland.
    Dubach UC; Levy PS; Minder F
    Helv Med Acta; 1968 Nov; 34(4):297-312. PubMed ID: 5704615
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--I. Experimental studies on the urotoxicity of alkylating compounds.
    Brock N; Pohl J; Stekar J
    Eur J Cancer (1965); 1981 Jun; 17(6):595-607. PubMed ID: 7308258
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcinogenicity of analgesics: long-term treatment of Sprague-Dawley rats with phenacetin, phenazone, caffeine and paracetamol (acetamidophen).
    Johansson SL
    Int J Cancer; 1981; 27(4):521-9. PubMed ID: 7275356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What do we know about occupational diseases of the kidney and urinary tract?].
    Wolf H
    Ugeskr Laeger; 1983 Dec; 145(50):3914-6. PubMed ID: 6665918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.